Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies

International Journal of Cancer

Volumn 138, Issue 10, 2016, Pages 2346-2356

  Sisti, Julia S ^a,b,c   Collins, Laura C ^d   Beck, Andrew H ^d   Tamimi, Rulla M ^a,b   Rosner, Bernard A ^b   Eliassen, A Heather ^a,b,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e CHANNING LABORATORY   (United States)

Author keywords

breast cancer; lactation; molecular subtypes; pregnancy; reproductive risk factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; ARTICLE; BASAL LIKE BREAST CANCER; BREAST CANCER; BREAST FEEDING; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATION; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; METASTASIS; PARITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTIVE HEALTH; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; BREAST NEOPLASMS; CANCER GRADING; CANCER STAGING; GENETICS; HEALTH SURVEY; MIDDLE AGED; NURSE; REPRODUCTIVE HISTORY; RISK FACTOR; TUMOR VOLUME; UNITED STATES;

ADULT; BIOMARKERS, TUMOR; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NURSES; PUBLIC HEALTH SURVEILLANCE; REPRODUCTIVE HISTORY; RISK FACTORS; TUMOR BURDEN; UNITED STATES;

EID: 84959924132     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29968     Document Type: Article

References (50)

1. Perou CM, Sørlie T, Eisen MB, et al., Molecular portraits of human breast tumours. Nature 2000; 406: 747-52.
2. Sørlie T, Perou CM, Tibshirani R, et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-74.
3. Sørlie T, Wang Y, Xiao C, et al., BMC Genomics 2006; 7: 127.
4. Nielsen TO, Hsu FD, Jensen K, et al., Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004; 10: 5367-74.
5. Cheang MCU, Chia SK, Voduc D, et al., Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009; 101: 736-50.
6. Brenton JD, Carey LA, Ahmed AA, et al., Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 2005; 23: 7350-60.
7. Abd El-Rehim DM, Pinder SE, Paish CE, et al., Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol 2004; 203: 661-71.
8. Cheang MCU, Voduc D, Bajdik C, et al., Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res 2008; 14: 1368-76.
9. Sotiriou C, Neo S-Y, McShane LM, et al., Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003; 100: 10393-8.
10. Parker JS, Mullins M, Cheang MCU, et al., Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009; 27: 1160-7.
11. Lacroix M, Toillon R-A, Leclercq G., Stable "portrait" of breast tumors during progression: data from biology, pathology and genetics. Endocr Relat Cancer 2004; 11: 497-522.
12. Ma H, Bernstein L, Pike MC, et al., Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8: R43.
13. Yang XR, Chang-Claude J, Goode EL, et al., Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011; 103: 250-63.
14. Althuis MD, Fergenbaum JH, Garcia-Closas M, et al., Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomark Prev 2004; 13: 1558-68.
15. Anderson KN, Schwab RB, Martinez ME., Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 2014; 144: 1-10.
16. Palmer JR, Viscidi E, Troester MA, et al., Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium. J Natl Cancer Inst 2014; 106.
17. Ambrosone CB, Zirpoli G, Ruszczyk M, et al., Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women's Circle of Health Study. Cancer Causes Control 2014; 25: 259-65.
18. Tamimi RM, Colditz GA, Hazra A, et al., Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat 2012; 131: 159-67.
19. Millikan RC, Newman B, Tse C-K, et al., Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; 109: 123-39.
20. Yang XR, Sherman ME, Rimm DL, et al., Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer. Epidemiol Biomark Prev 2007; 16: 439-43.
21. Collins LC, Marotti JD, Baer HJ, et al., Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst 2008; 100: 218-21.
22. Tamimi RM, Baer HJ, Marotti J, et al., Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 2008; 10: R67.
23. van de Rijn M, Perou CM, Tibshirani R, et al., Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002; 161: 1991-6.
24. Goldhirsch A, Winer EP, Coates AS, et al., Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013; 24: 2206-23.
25. Pike MC, Krailo MD, Henderson BE, et al., " Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature 1983; 303: 767-70.
26. Rosner B, Colditz GA, Willett WC., Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994; 139: 819-35.
27. Colditz GA, Rosner B., Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000; 152: 950-64.
28. Lunn M, McNeil D., Applying Cox regression to competing risks. Biometrics 1995; 51: 524-32.
29. Polyak K., Heterogeneity in breast cancer. J Clin Invest 2011; 121: 3786-8.
30. Key T, Appleby P, Barnes I, et al., Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002; 94: 606-16.
31. Key TJ, Appleby PN, Reeves GK, et al., Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 2013; 14: 1009-19.
32. Key TJ, Appleby PN, Reeves GK, et al., Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 2011; 105: 709-22.
33. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 2012; 13: 1141-51.
34. Colditz GA, Frazier AL., Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomark Prev 1995; 4: 567-71.
35. Chen WY, Hankinson SE, Schnitt SJ, et al., Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 2004; 101: 1490-500.
36. Chlebowski RT, Anderson GL, Gass M, et al., WHI. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010; 304: 1684-92.
37. Russo J, Tay LK, Russo IH., Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982; 2: 5-73.
38. Lambe M, Hsieh C, Trichopoulos D, et al., Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994; 331: 5-9.
39. Albrektsen G, Heuch I, Hansen S, et al., Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 2005; 92: 167-75.
40. Trichopoulos D, Hsieh CC, MacMahon B, et al., Age at any birth and breast cancer risk. Int J Cancer 1983; 31: 701-4.
41. Li CI, Malone KE, Daling JR, et al., Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 2008; 167: 230-9.
42. Ritte R, Tikk K, Lukanova A, et al., Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer 2013; 13: 584.
43. Chung S, Park SK, Sung H, et al., Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study. Breast Cancer Res Treat 2013; 140: 557-65.
44. Ambrosone CB, Zirpoli G, Hong C-C, et al., Important role of menarche in development of estrogen receptor-negative breast cancer in African American women. J Natl Cancer Inst 2015; 107.
45. Li CI, Beaber EF, Tang M-TC, et al., Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age. Breast Cancer Res Treat 2013; 137: 579-87.
46. Colditz GA, Rosner BA, Chen WY, et al., Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004; 96: 218-28.
47. Rosner B, Glynn RJ, Tamimi RM, et al., Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. Am J Epidemiol 2013; 178: 296-308.
48. Phipps AI, Buist DSM, Malone KE, et al., Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011; 22: 399-405.
49. Lipworth L, Bailey LR, Trichopoulos D., History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 2000; 92: 302-12.
50. Inwald EC, Klinkhammer-Schalke M, Hofstädter F, et al., Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 2013; 139: 539-52.